These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25174012)

  • 1. Compatibility of conivaptan injection with select cardiovascular medications.
    Howard MS; Boddu SH; Mauro VF; Churchwell MD
    Am J Health Syst Pharm; 2014 Sep; 71(18):1534-5. PubMed ID: 25174012
    [No Abstract]   [Full Text] [Related]  

  • 2. Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside.
    Schaaf LJ; Tremel LC; Wulf BG; Vernon KK
    J Clin Pharm Ther; 1990 Oct; 15(5):371-6. PubMed ID: 1963175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
    J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical compatibility of milrinone 1 mg/mL with select cardiovascular medications during simulated Y-site administration.
    Griffith SN; Stapleton E; Padilla S; Mruk A; Thomas CA
    Am J Health Syst Pharm; 2020 Nov; 77(23):1938-1940. PubMed ID: 32991671
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemical compatibility of inotropic and vasoactive agents delivered via a multiple line infusion system.
    Grillo JA; Gonzalez ER; Ramaiya A; Karnes HT; Wells B
    Crit Care Med; 1995 Jun; 23(6):1061-6. PubMed ID: 7774217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical compatibility of milrinone lactate injection with intravenous drugs commonly used in the pediatric intensive care unit.
    Veltri MA; Conner KG
    Am J Health Syst Pharm; 2002 Mar; 59(5):452-4. PubMed ID: 11887412
    [No Abstract]   [Full Text] [Related]  

  • 7. Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine.
    Cruz KCE; Churchwell MD; Mauro VF; Boddu SHS
    Am J Health Syst Pharm; 2018 Apr; 75(8):510-512. PubMed ID: 29626000
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous infusions of nitroprusside, dobutamine, and nitroglycerin are compatible.
    Horrow JC; Digregorio GJ; Barbieri EJ; Rupp E
    Crit Care Med; 1990 Aug; 18(8):858-61. PubMed ID: 2116261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A; Schmelzle T; Simon R
    Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents.
    Newland AM; Mauro VF; Alexander KS
    Am J Health Syst Pharm; 2009 Jun; 66(11):986-7. PubMed ID: 19451606
    [No Abstract]   [Full Text] [Related]  

  • 11. Bretylium tosylate intravenous admixture compatibility. II: Dopamine, lidocaine, procainamide, and nitroglycerin.
    Lee YC; Malick AW; Amann AH; Baaske DM; Shah JJ; Wagenknecht DM; Carter JE
    Am J Hosp Pharm; 1981 Feb; 38(2):183-7. PubMed ID: 6782870
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability of dopamine hydrochloride injection in the presence of dobutamine hydrochloride, tolazoline hydrochloride, and theophylline injections.
    Bhatt-Mehta V; Nahata MC
    J Perinatol; 1990 Jun; 10(2):129-33. PubMed ID: 2358894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
    Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
    Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure.
    Loh E; Elkayam U; Cody R; Bristow M; Jaski B; Colucci WS
    J Card Fail; 2001 Jun; 7(2):114-21. PubMed ID: 11420762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical compatibility of milrinone with levofloxacin and ceftriaxone injection.
    Ross AR; Boddu SHS; Mauro VF; Churchwell MD
    Am J Health Syst Pharm; 2018 Jul; 75(14):1010-1012. PubMed ID: 29987058
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of visual and turbidimetric methods for determining short-term compatibility of intravenous critical-care drugs.
    Dasta JF; Hale KN; Stauffer GL; Tschampel MM
    Am J Hosp Pharm; 1988 Nov; 45(11):2361-6. PubMed ID: 3228093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial ischaemia following cocaine and adrenaline exposure in a child during an ophthalmological procedure.
    McGovern E; Moylett E; McMahon CJ
    Ir Med J; 2015 Mar; 108(3):89-90. PubMed ID: 25876303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of milrinone versus nitroglycerin in controlling pulmonary arterial hypertension induced by intravenous injections of absolute ethanol in anesthetized dogs.
    Kim JS; Nam MH; Do YS; Lee CJ; Kim CS; Sim WS; Park KB; Lee SH; Han JS; Shin BS; Kim HY
    J Vasc Interv Radiol; 2010 Jun; 21(6):882-7. PubMed ID: 20418111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.